Conacher ID. Post-thoracotomy analgesia. Anesthesiol Clin North Am 2001; 19: 611-625
Liu S, Carpenter RL, Neal JM. Epidural anesthesia and analgesia. Anesthesiology 1995; 82: 1474-1506
Katz J, Jackson M, Kavanagh BP, Sandler AN. Acute pain after thoracic surgery predicts long-term post-thoracotomy pain. Clin J Pain 1996; 12: 50-55
Marret E, Kurdi O, Zufferey P, Bonnet F. Effects of nonsteroidal antiinflammatory drugs on patient-controlled analgesia morphine side effects: meta-analysis of randomized controlled trials. Anesthesiology 2005; 102: 1249-1260
Bigler D, Moller J, Kamp-Jensen M, Berthelsen P, Hjortso NC, Kehlet H. Effect of piroxicam in addition to continuous thoracic epidural bupivacaine and morphine on postoperative pain and lung function after thoracotomy. Acta Anaesthesiol Scand 1992; 36: 647-650
Marret E, Flahault A, Samama CM, Bonnet F. Effects of postoperative, non-steroidal anti-inflammatory drugs on bleeding risk after tonsillectomy: meta-analysis of randomized controlled trials. Anesthesiology 2003; 98: 1497-1502
Forrest JB, Camu F, Greer IA et al. Ketorolac, diclofenac and ketoprofen are equally safe for pain relief after major surgery. Br J Anaesth 2002; 88: 227-233
Daniels SE, Grossman EH, Kuss ME et al. A double blind randomised comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post-oral surgery pain model. Clin Ther 2001; 23: 1018-1031
Bainbridge D, Cheng DC, Martin JE, Novick R, and The Evidence- Based Perioperative Clinical Outcomes Research (EPiCOR) Group. NSAID-analgesia, pain control and morbidity in cardiothoracic surgery. Can J Anesth 2006; 53: 46-59
Greyn J, Lauwers MH, Vanlersberghe C et al. COX-1 and COX-2 inhibition: current status and future perspective. Acta Anaesthesiol Belg 1998; 49: 175-183
Moiniche S, Kehlet H, Dahl JB et al. Qualitative and quantitative systematic review of preemptive analgesia for postoperative pain relief. The role of timing of analgesia. Anesthesiology 2002; 96: 725-741
Ong CKS, Lirk P, Seymour RA et al. The efficacy of preemptive analgesia for acute postoperative pain management: a metaanalysis. Anesth Analg 2005; 100: 757-773
Buvanendran A, Kroin JS, Tuman KJ et al. Effects of perioperative administration of a selective cyclooxygenase2 inhibitor on pain management and recovery of function after knee replacement: a randomized control trial. J Am Med Assoc 2003; 290: 2411-2418
Guignard B, Bossard AE, Coste C et al. Acute opioid tolerance; remifentanil increases postoperative pain and morphine requirements. Anesthesiology 2000; 93: 409-417
Tröster A, Sittl R, Singler B et al. Modulation of remifentanilinduced analgesia and postinfusion hyperalgesia by parecoxib in humans. Anesthesiology 2006; 105: 1016-1023
Zhao SZ, Reynolds MW, Lefkowith J, Whelton A, Arellano FM. A comparison of renal related adverse drug reactions between rofecoxib and celecoxib,basedontheworldhealthorganization/Uppsala monitoring centre safety database. Clin Ther 2001; 23: 1478-1490
Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. J Am Med Assoc 2001; 286: 954-959 (Pubitemid 33010342)
Solomon SD, McMurray JJV, Pfeffer MA et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005; 352: 1092-1102
Nussmeier NA, Whelton AA, Brown MT et al. Complications of the cox-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 2005; 352: 1081-1091
Nussmeier NA, Whelton AA, Brown MT et al. Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery. Anesthesiology 2006; 104: 518-526
